ArticleThe Journal of physiology2026
Old dog, new trick: Charybdotoxin as a novel ryanodine receptor blocker.
Zsuzsanna Édua Magyar, Judit Hevesi, Frigyes Mészáros, Zsolt Bozsó, János Szolomájer, Gábor Tóth, György Panyi, Péter Enyedi, Zoltán Varga, Zoltán Pethő and 1 more
Abstract read
In one paragraphArticle in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Zsuzsanna Édua MagyarDepartment of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Judit HevesiDepartment of Orthodontics, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary.
Frigyes MészárosDepartment of Physiology, Semmelweis University, Budapest, Hungary.
Zsolt BozsóDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, MTA-SZTE Biomimetic Systems Research Group, Eötvös Loránd Research Network (ELKH), University of Szeged, Szeged, Hungary.ORCID https://orcid.org/0000-0002-5713-3096 János SzolomájerDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, MTA-SZTE Biomimetic Systems Research Group, Eötvös Loránd Research Network (ELKH), University of Szeged, Szeged, Hungary.
Gábor TóthDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, MTA-SZTE Biomimetic Systems Research Group, Eötvös Loránd Research Network (ELKH), University of Szeged, Szeged, Hungary.
Péter EnyediDepartment of Physiology, Semmelweis University, Budapest, Hungary.
Funding
Deutsche Forschungsgemeinschaft 3917/2-1European Union and the European Regional Development Fund EFOP-3.6.2-16-2017-00006János Bolyai Research Scholarship of the Hungarian Academy of Sciences JAMinistry of Innovation and Technology of Hungary and National Research, Development and Innovation Fund TKP2021-EGA-24National Research, Development and Innovation Fund of Hungary NKFIH FK144576
6 · The paper itselfAbstract
Ryanodine receptors (RyRs) are Ca
Indexed as
Calcium Channel BlockersCharybdotoxinRyanodine Receptor Calcium Release ChannelAnimalsMuscle, SkeletalPotassium Channel BlockersCalcium Channel BlockersCharybdotoxinPotassium Channel BlockersRyanodine Receptor Calcium Release Channelcharybdotoxinion channelsryanodine receptorsingle channel
Identifiers
PMID42574661
PMCPMC13532853
What OpenQuestion holds
Textmetadata
Read underepoch 390